Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from LABORATORIO REIG JOFRE ( (ES:RJF) ) is now available.
Reig Jofre announced details of its liquidity contract movements for the fourth quarter of 2024, conducted with SOLVENTIS, A.V., S.A. The report outlines the shares bought and sold, alongside the financial transactions and expenses incurred during this period, reflecting the company’s ongoing commitment to maintaining market stability and meeting regulatory requirements.
More about LABORATORIO REIG JOFRE
Laboratorio Reig Jofre is a company operating in the pharmaceutical industry, focusing on the development and production of health and wellness products. Their primary services include the manufacturing and marketing of pharmaceutical products, with a market focus on innovation and international expansion.
YTD Price Performance: 1.57%
Average Trading Volume: 329
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: €206.5M
Learn more about RJF stock on TipRanks’ Stock Analysis page.